Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP. [electronic resource]
- Pharmaceutical research Mar 2016
- 590-602 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1573-904X
10.1007/s11095-015-1812-1 doi
ATP Binding Cassette Transporter, Subfamily G, Member 2 ATP-Binding Cassette Transporters--antagonists & inhibitors Animals Cell Line Cell Line, Transformed Curcumin--pharmacology Dogs Glucuronides--metabolism Glucuronosyltransferase--metabolism HeLa Cells Humans Madin Darby Canine Kidney Cells Male Membrane Transport Proteins Metabolic Detoxication, Phase II--physiology Mice Mice, Knockout Multidrug Resistance-Associated Protein 2 Multidrug Resistance-Associated Proteins--antagonists & inhibitors Neoplasm Proteins--antagonists & inhibitors Resveratrol Stilbenes--metabolism UDP-Glucuronosyltransferase 1A9